Alan, the Paris-based health insurer, agreed a €480m (about $552m) funding round led by Prosus, the companies announced on 24 June 2026. The round values Alan at €5.5bn (about $6.3bn). Tech.eu and The Next Web described it as a Series G.
Prosus is investing €400m (about $460m) of the total through a combination of primary and secondary equity, meaning part of its money buys existing shares rather than going to the company. The split between the two was not disclosed. Existing investors Teachers' Venture Growth and Index Ventures also took part, alongside new investor Dara Holdings.
The deal has not yet closed. Prosus said closing is subject to regulatory approvals, including from the relevant French financial authorities. Alan is supervised by the French Prudential Supervision and Resolution Authority (ACPR).
“Healthcare presents one of the most significant global opportunities for AI-led transformation.”Fahd Beg, Head of Investments, Prosus Group
What Alan does
Alan sells health insurance to companies and individuals and combines it with care and prevention services on one AI-based platform, a model its co-founder and chief executive Jean-Charles Samuelian-Werve calls "prevention insurance". According to Pulse 2.0, the platform gives members access to doctors, reimbursement services and customer support seven days a week.
The company operates in France, Spain, Belgium and Canada. Prosus said Alan covers more than 1.1 million people and more than 37,000 businesses, as well as self-employed professionals and retirees, and employs more than 850 people.
Alan was founded in 2016 by Samuelian-Werve and Charles Gorintin, its chief technology officer, according to The Next Web. BusinessDay reported that the company says it has grown with limited additions to headcount, which it attributes to its use of AI.
Revenue and the case for the deal
Alan's annual recurring revenue passed €800m (about $920m) in the first quarter of 2026, up 53% from a year earlier, according to Prosus. The insurer is profitable in France, its largest market. Neither company gave a profit figure for the group as a whole.
Prosus, the Amsterdam-listed unit of Naspers, said the investment would extend its consumer business into healthcare. Fahd Beg, its head of investments, said healthcare was one of the largest opportunities for AI-led change and that Alan had built a platform where insurance, prevention and care support each other.
Samuelian-Werve said Alan chose Prosus for its experience in international expansion, Tech.eu reported.
What the money is for
Alan will use the funding to accelerate international expansion, scale its consumer offering and invest in AI-led product development, Prosus said. As part of the partnership, Alan will get access to Prosus's Large Commerce Model, an AI model developed by Prosus.
Pulse 2.0 reported that the plan includes entering large markets where Prosus already has a strong position. The companies did not name those markets.
The funding so far
The new round came about three months after Alan raised €100m (about $115m) at a €5bn (about $5.75bn) valuation, according to The Next Web. The lead investor in that round was not reported.
Including this round, Alan has raised more than €1.2bn (about $1.4bn) in total, according to Tech.eu and The Next Web. Teachers' Venture Growth and Index Ventures, both existing shareholders, returned for the Series G.
Company website: alan.com